18-month-old on levetiracetam after febrile status epilepticus—initially told 6 months, now advised 2 seizure-free years. Is this standard practice?
Hi doctors,
I'm the parent of an 18-month-old and would really appreciate an evidence-based opinion.
At 13 months, my child had febrile status epilepticus. There were two seizure episodes during the same febrile illness, each lasting about 20 minutes. The second occurred after reaching the hospital. Child required intubation and PICU admission.
The EEG was normal, and the treating team felt MRI wasn't indicated. Since then, there have been no further seizures.
Levetiracetam (Levipil) was started at 2 mL twice daily for 3 months, then reduced to 1 mL twice daily, which is the current dose.
My confusion is this: we clearly remember being told at discharge that the medication would be continued for 6 months and then reviewed. At the recent follow-up, the pediatrician said there was no documentation of that plan and now recommends continuing levetiracetam for 2 seizure-free years, based on their clinical judgment.
Around a month after starting the medication, we began noticing behavioral changes. I know I'm a worried parent and some of these may simply be normal toddler behavior, so I'm not claiming the medication is definitely responsible.
However, compared with before the seizure and treatment, we've noticed persistent mild-to-moderate irritability, frequent crying, aggression/tantrums, hyperactivity, poor sleep with frequent night waking, clinginess, reduced attention, slower speech progress, less interest in social interaction and play, occasional head banging, reduced appetite, and some clumsiness.
We live in an area with very limited access to pediatric neurology and developmental/behavioral specialists, so getting another expert opinion isn't easy.
My questions are:
Is 2 seizure-free years of levetiracetam after febrile status epilepticus (normal EEG, no further seizures) a common or evidence-based approach?
Is there any guideline or literature supporting this duration, or is it mainly individualized?
How commonly do you see behavioral side effects from levetiracetam in toddlers, and do they typically improve after tapering if the medication is no longer needed?
I'm not asking whether I should stop the medication on my own. I'm simply trying to understand whether this management is in line with current pediatric neurology practice.
Thank you!
Engineer_parent